Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01312480 · ClinicalTrials.gov registry record · NA

Adolescent Smoking Cessation in Pediatric Primary Care

A NA study of Tobacco Cessation and Media Use, sponsored by American Academy of Pediatrics.

Completed
Registry status
NA
Development phase
10,967
Enrollment target
1
Study location

NCT01312480: Completed NA study of Tobacco Cessation and Media Use, sponsored by American Academy of Pediatrics.

NCT01312480 is a NA study of Tobacco Cessation and Media Use that has completed, run by American Academy of Pediatrics. The registered enrollment target is 10,967 participants, above the 299-participant average among 8 other Tobacco Cessation trials with a reported enrollment target (3568% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01312480, a NA study of Tobacco Cessation and Media Use, has completed, sponsored by American Academy of Pediatrics.

COMPLETED
Registry status
NA
Development phase
10,967 participants
Enrollment target
1
Study location

Study Summary

This is a study of the effectiveness of adolescent smoking cessation interventions in pediatric primary care settings. Our specific aims are to: 1. Demonstrate providers' fidelity to guidelines for tobacco counseling and delivery of cessation interventions using practice system changes over time, (including systematic screening using charting tools and linkages to adjunct materials, including self-help handouts and Internet resources); and 2. Assess the impact of primary care provider counseling interventions on adolescent smoking cessation. We hypothesize that adolescents who receive guidelines-based clinician-delivered smoking cessation counseling at primary care visits will be more likely to make quit attempts and more likely to remain abstinent (with better long term cessation rates) at 6 and 12 months after intervention, compared to those who do not receive interventions. In addition, we hypothesize that successful referral to stage-based self-help adjuncts, and more adjunct use will be associated with more quit attempts and better long-term cessation rates. We will evaluate provider interventions in up to 120 pediatric practices, recruited from the American Academy of Pediatric's Pediatric Research in Office Settings (PROS) practice-based research network. Adolescents presenting for care will complete a short baseline survey prior to their doctor-visit, and a percentage of participants will be surveyed by phone 4-6 weeks after their visits to assess quit attempts and short-term cessation, and again at 6 and 12 months to evaluate long-term cessation outcomes. We will describe the patterns of smoking among youth, and explore how much receiving interventions affects motivation, quitting, abstinence/relapse attitudes, attitudes and use of adjunct strategies, and other smoking behaviors for adolescent smokers.

Primary Outcome

Via phone interview, adolescents will be asked to report their current smoking status, any quit-attempts, success of those quit-attempts, abstinence from tobacco products, and use of adjunct resources in the time since their initial doctor's visit.

Interventions

  • OTHER 5A's Model
  • OTHER Media Use Assessment

Study Locations (1)

Illinois

  • American Academy of Pediatrics - Elk Grove Village

Trial Details

FieldValue
Enrollment Target 10,967 participants
Start Date 2011-05
Est. Completion 2017-04
Phase NA
American Academy of Pediatrics

3 total trials

What the finished NCT01312480 record still lists

NCT01312480 is an interventional study that assigns participants to a tested intervention. Its 10,967 participants enrollment target places it among the larger protocols in the corpus, above the 299-participant average among 8 other Tobacco Cessation trials with a reported enrollment target (3568% higher).

The record links to 2 conditions, with Tobacco Cessation appearing as the primary indexed condition, and to 2 interventions - of which 5A's Model is the first listed.

NCT01312480 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01312480 about?

NCT01312480 is a clinical study titled "Adolescent Smoking Cessation in Pediatric Primary Care". This is a study of the effectiveness of adolescent smoking cessation interventions in pediatric primary care settings. Our specific aims are to: 1. Demonstrate providers' fidelity to guidelines for tobacco counseling and delivery of cessation interventions using practice system changes over time, (...

What is the current status of trial NCT01312480?

This trial is currently completed. It is a NA study. The enrollment target is 10,967 participants. The study started on 2011-05. Estimated completion is 2017-04.

What conditions does trial NCT01312480 study?

This clinical trial studies the following conditions: Tobacco Cessation, Media Use.

What interventions are being tested in trial NCT01312480?

The interventions under investigation include: 5A's Model (OTHER), Media Use Assessment (OTHER).

Who is sponsoring clinical trial NCT01312480?

This trial is sponsored by American Academy of Pediatrics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01312480 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01312480's enrollment target sits among peer trials

10,967 1st of 8 higher than 8 of 8 other Tobacco Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06531824 · 11,000 participants · Phase 3

    EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  • NCT07136012 · 11,000 participants · Phase 3

    OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • NCT07181109 · 11,000 participants · Phase 3

    Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • NCT06736951 · 10,890 participants · NA

    Modifying the Inpatient Environment to Reduce Delirium in Older Adults

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01312480, the US trial registry maintained by the National Library of Medicine. NCT01312480 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.